Edwards Lifesciences (EW) Tops Q2 EPS by 20c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent slips in choppy session as investors weigh attacks on ships, Saudi energy
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
Edwards Lifesciences (EW) PT Raised to $155 at Canaccord Genuity on 2Q Beat; 'Keep Buying... Upside to Raised Guidance in the Cards'
July 27, 2017 10:48 AM EDTCanaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $155.00 (from $150.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst Jason Mills notes the company delivered a second quarter earnings per share and revenue results above consensus projections... More
Edwards Lifesciences (EW) PT Raised to $130 at Stifel; Reiterates Buy
July 27, 2017 8:30 AM EDTStifel raised its price target on Edwards Lifesciences (NYSE: EW) to $130.00 (from $118.00) while maintaining a Buy rating. For 3Q17, the company anticipates revenue between $810M-$850M with EPS at $0.80-$0.90 (mid-point: $0.85).
For 2017, Edwards now expects full-year revenue at the higher end of the $3.2 billion... More
Edwards Lifesciences (EW) PT Raised to $132 at Jefferies
July 27, 2017 7:33 AM EDTJefferies raised its price target on Edwards Lifesciences (NYSE: EW) to $132.00 (from $115.00) while maintaining a Buy rating following the company's 2Q. EW put up another impressive TAVR Q with +23.3% underlying y/y growth and +7% growth sequentially. After adding back $22.5mn of German inventory... More



